Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
HERC4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ARIH1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
STX16 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CYLC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KANSL1L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101928818 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
MIR205 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BTRC - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
FAM234B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC40A1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GNG2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ECT2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
APAF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DLEU2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NREP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ANKRD13D - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on